Preparing Health Plans for Risk Adjustment in the Age of Serialization Technology

Serialization technology has a significant impact on ensuring product integrity and regulatory compliance across various industries, including pharmaceuticals. These advancements help improve security, efficiency, and innovation on a global scale.

Health plans are advised to prepare for changes in risk adjustment and star ratings by implementing strategies to adapt to new requirements. For instance, CMS has introduced a Health Equity Index (HEI) reward as part of its Stars program, which will influence Star Ratings in 2027. Plans need to collect member data on all measures included in the HEI to meet these new standards.

OpenAI recently released ChatGPT, its latest chatbot technology, which is still in a partially finished state. The new technology, GPT-4o, has much potential to demonstrate the capabilities of artificial intelligence in communication and interaction.

Johnson & Johnson has successfully acquired Shockwave Medical, with the latter now operating as a business unit within Johnson & Johnson MedTech. This acquisition marks a significant development for both companies in the healthcare industry.

Dealing with drug recalls can be costly and time-consuming for hospital pharmacies. Beth Riggio, VP of Product Management, Global Products & Solutions at Cencora, discusses solutions to improve the efficiency of the drug recall process with Pharmaceutical Executive. If you have news or updates to share in the pharmaceutical industry, reach out to Social Media Editor Miranda Schmalfuhs to be featured in Pharma Pulse.